Average time varying normalised VL EMG during the entire jump across conditions. by Eric Yung-Sheng Su (13015474)

Fig 3 - by Belinda Kweka (9931483)

“…</b> By OGTT, PD/DM was prevalent in 32/52 (61.5%) of participants with homozygous α⁺ AT, 90/186 (48.4%) of those with heterozygous α⁺ AT, and 89/193 (46.1%) of those without α-thalassemia (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0244782#pone.0244782.t003" target="_blank">Table 3</a>). …”

Data_Sheet_1_CCL5 promotes LFA-1 expression in Th17 cells and induces LCK and ZAP70 activation in a mouse model of Parkinson’s disease.pdf by Jingwei Zhao (428571)

DataSheet_5_Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical Cancer.pdf by Renata A. M. Rossetti (9659426)

Image5_Pharmacological investigation of brucine anti-ulcer potential.TIF by Muhammad Noman (4266664)

Down-regulation of Na_V1.8 and Na_V1.9 expressions in rat DRG neurons by antisense oligodeoxynucleotides (AS ODNs). by Yao-Qing Yu (221636)

“…(D) Averaged percent changes in the amount of Na_V1.8 or Na_V1.9 protein level in DRGs of naive and CFA-treated rats (n = 5). …”

Table_5_Peach Fruit Development: A Comparative Proteomic Study Between Endocarp and Mesocarp at Very Early Stages Underpins the Main Differential Biochemical Processes Between Thes... by Carlos E. Rodriguez (3615815)

Presentation_1_Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease.pptx by Annamaria Vallelunga (11183250)

“…We measured levels of miRNAs using quantitative PCR and compared the levels of miR-96-5p and miR-339-5p among PD, MSA and HC groups using a one-way analysis of variance. …”

miR-129-5p directly targets APC-mRNA at 3′-UTR and protein expression of genes regulated by miR-129-5p. by MingHua Li (3522803)

“…<p>(A) The predicted miR-129-5p target site on the APC 3′-UTR. …”

Relative quantification comparisons of SP-A1 (A), SP-A2 (B), and SP-D (C) in ULTR treated with 5, 10 and 20 μg/ml of rhSPD after 6 and 12h (*p<0.05, **p<0.01, ***p<0.001). by Georgios Sotiriadis (834262)

“…<p>rhSP-D treatments resulted in an increase of SP-A1, SP-A2 and SP-D mRNA expression at 6 h at 5 and 10 μg/ml. …”

Related to Fig 1. by Mohammad Nafees Ansari (22232505)

“…(<b>J</b>–<b>M</b>) Immunoblot confirms silencing of UGCG in MCF-7 and BT-474 cells (J, L) and cell proliferation assay demonstrates a decrease in proliferation in MCF-7_UGCG^SL and BT-474_UGCG^SL cells over MCF-7_SCRAM^SL (mean ± SEM, <i>n</i> = 5) and BT-474_SCRAM^SL cells (mean ± SEM, <i>n</i> = 3) (K, M). …”

Luminal tumors have a deregulated sphingolipid and ganglioside profile and high RICTOR expression. by Mohammad Nafees Ansari (22232505)

“…(<b>D</b>–<b>H</b>) Absolute quantification (mean ± SEM, <i>n</i> = 5) of GM3 (D), GD3 (E), GD2 (F), GM2 (G), and GM1 (H) gangliosides in luminal tumor tissues and adjacent normal tissues shows an increase in GM3 and GD3 gangliosides and a decrease in GM1 gangliosides in luminal tumor tissues. …”

Presentation_5_Deforestation Impacts on Orographic Precipitation in the Tropical Andes.PPTX by Masih Eghdami (6901853)

“…Changes in rainfall amount and intensity result in runoff decreases of 5–10% at the event-scale for the CAI case. …”

Supplementary Material for: Endothelial Interferon Regulatory Factor 1 Regulates Lipopolysaccharide-Induced VCAM-1 Expression Independent of NFκB by Yan R. (4177834)

<b><i>Agaricus bisporus</i></b><b> mushrooms are supplied with water through both apoplastic as well as symplastic routes from distinct substrate layers</b> by Koen C. Herman (20386205)

DataSheet_5_Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer.pd... by Jeroen H. A. Creemers (9561569)

Image_4_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

“…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”

Image_6_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

“…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”

Image_7_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

“…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”

Image_3_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

“…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”